Cite
MLA Citation
et al.. “Real-World Efficacy and Safety of Ritonavir-Boosted Paritaprevir, Ombitasvir, Dasabuvir ± Ribavirin for Hepatitis C Genotype 1 – Final Results of the REV1TAL Study.” Antiviral therapy, vol. 22, no. 8, 2017, pp. 699–710. http://access.bl.uk/ark:/81055/vdc_100128731214.0x000021